Monday, August 17, 2015

Penumbra Files For IPO On NYSE

Alameda-based Penumbra, which develops medical devices for treating stroke, has filed for a $115M IPO. According to the company, it has applied to list on the New York Stock Exchange as PEN. The IPO is being led by J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, and Canaccord Genuity. The company is backed by Fidelity.